The role of eosinophils and neutrophils in helminth-induced keratitis

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 7, 1998, Pages 1176-1182

  Pearlman, Eric ^a,b   Hall, Laurie R ^a   Higgins, Alan W ^a   Bardenstein, David S ^a   Diaconu, Eugenia ^a   Hazlett, Fred E ^a   Albright, Jamie ^a   Kazura, James W ^a   Lass, Jonathan H ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; CORNEA STROMA; EOSINOPHIL; GENE EXPRESSION; HELMINTH; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KERATITIS; MOUSE; NEUTROPHIL; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRIORITY JOURNAL; SLIT LAMP;

ANIMALS; ANTIGENS, HELMINTH; CORNEA; CORNEAL NEOVASCULARIZATION; CORNEAL OPACITY; CYTOKINES; DNA PRIMERS; EOSINOPHILS; FEMALE; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-5; KERATITIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS, OCULAR; SPLEEN;

EID: 0031806080     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. World Health Organization Expert Committee on Onchocerciasis. Onchocerciasis and its control. World Health Organ Tech Rept. 1995;852:103.
2. World Health Organization Expert Committee on Onchocerciasis. Third Report. World Health Organ Tech Rept. 1987;752:167.
3. Ottesen E. Immune responsiveness and the pathogenesis of human Onchocerciasis. J Infect Dis. 1995;171:659-671.
4. Pearlman E. Experimental onchocercal keratitis. Parasitol Today. 1996;12:261-267.
5. Duke BO, Anderson J. A comparison of the lesions produced in the cornea of the rabbit eye by microfilariae of the forest and Sudansavanna strains of Onchocerca volvulus from Cameroon. 1. The clinical picture. Z Tropenmed Parasitol. 1972;23:354-368.
6. Duke BO, Garner A. Reactions to subconjunctival inoculation of Onchocerca volvulus microfilariae in pre-immunized rabbits. Z Tropenmed Parasitol. 1975;26:435-448.
7. Donnelly JJ, Rockey JH, Bianco AE, Soulsby EJL. Ocular immunopathologic findings of experimental Onchocerciasis. Arch Ophthalmol. 1984;102:628-634.
8. Sakla AA, Donnelly JJ, Lok JB, Khatami M, Rockey JH. Punctate keratitis induced by suhconjunctivally injected microfilariae of Onchocerca lienalis. Arch Ophthalmol. 1986;104:894-898.
9. Chakravarti B, Lass JH, Diaconu E, et al. Immune-mediated Onchocerca volvulus sclerosing keratitis in the mouse. Exp Eye Res. 1993;57:21-27.
10. Chakravarti B, Herring TA, Lass JH, et al. Infiltration of CD4+ T cells into cornea during development of Onchocerca volvulus-induced experimental sclerosing keratitis in mice. Cell Immunol. 1994;159:306-314.
11. Gallin MY, Murray D, Lass JH, Grossniklaus HE, Greene BM. Experimental interstitial keratitis induced by Onchocerca volvulus antigens. Arch Ophthalmol. 1988;106:1447-1452.
12. Pearlman E, Lass J, Bardenstein D, et al. Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J Exp Med. 1995;182:931-940.
13. Pearlman E, Lass J, Bardenstein D, et al. Onchocerca volvulus -mediated keratitis: cytokine production by IL-4-deficient mice. Exp Parasitol. 1996;84:274-281.
14. Pearlman E, Lass JH, Bardenstein DS, et al. IL-12 exacerbates helminth-mediated corneal pathology by augmenting cell recruitment and chemokine expression. J Immunol. 1997;158:827-833.
15. Bardenstein DS, Lass JH, Kazura JH, Pearlman E. Pleomorphism of stromal eosinophils in murine experimental onchocercal keratitis. Ocular Immunol Inflamm. 1997;5:157-163.
16. Kopf M, Brombacher F, Hodgkin P, et al. IL-5 deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 1996;4:1-20.
17. Hendricks RL, Weber PC, Taylor JL, et al. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. J Gen Virol. 1991;72:1601-1610.
18. Lee J, McGarry M, Farmer S, et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med. 1997;185:2143-2156.
19. Hirsch S, Gordon S. Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics. 1983;18:229-239.
20. Kwon B, Hazlett LD. Association of CD4+ T cell dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J Immunol. 1997;159:6283-6290.
21. Thomas J, Gangappa S, Kanangat S, Rouse B. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol. 1997;158:1383-1391.
22. Tumpey T, Chen S, Oakes J, Lausch R. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol. 1996;70:898-904.
23. Griffith T, Brunner T, Fletcher S, Green D, Ferguson T. Fas ligand-induced apoptosis as a mechanism of immune privilege (see comments). Science. 1995;270:1189-1192.
24. Stuart P, Griffith T, Usui N, et al. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest. 1997;99:396-402.
25. Tang Q, Chen W, Hendricks R. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J Immunol. 1997; 158: 1275-1283.
26. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80:2012-2020.
27. Moser R, Fehr J, Bruijnzeel PL. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol. 1992;149:1432-1438.
28. Moser R, Groscurth P, Carballido JM, et al. Interleukin-4 induces tissue eosinophilia in mice: correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils. J Lab Clin Med. 1993; 122:567-575.
29. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol. 1992;148:1086-1092.
30. Muller W, Weigl S, Deng X, Phillips D. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993;178: 449-460.
31. Vaporciyan A, DeLisser H, Yan H, et al. Involvement of plateletendothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science. 1993;262:1580-1582.
32. Tang Q, Hendricks R. Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J Exp Med. 1996;184:1435-1447.
33. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
34. Rothenberg ME, MacLean JA, Pearlman E, Leder P. Targeted disruption of the chemokine eotaxin partially reduces peripheral blood and antigen induced tissue eosinophilia. J Exp Med. 1997; 185:785-790.
35. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Anna Rev Med. 1993;44:85-101.
36. Trocme SD, Kephart GM, Allansmith MR, Bourne WM, Gleich GJ. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am J Ophthalmol. 1989;108: 57-63.
37. Trocme SD, Kephart GM, Bourne WM, Buckley RJ, Gleich GJ. Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. Am J Ophthalmol. 1993;115:640-643.
38. Trocme SD, Gleich GJ, Kephart GM, Zieske JD. Eosinophil granule major basic protein inhibition of corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1994;35:3051-3056.
39. Trocme S, Hallberg C, Gill K, et al. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest Ophthalmol Vis Sci. 1997;38:593-599.
40. Stingl P, Ross M, Gibson DW, Ribas J, Connor DH. A diagnostic patch test for onchocerciasis using topical diethylcarbamazine. Trans R Soc Trop Med Hyg. 1984;78:254-258.
41. Kephart G, Gleich G, Connor D, Gibson D, Ackerman S. Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine. Lab Invest. 1984;50:51-61.
42. Ackerman S, Kephart G, Francis H, et al. Eosinophil degranulation: an immunologie determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. J Immunol. 1990;144:3961-3969.
43. Pearlman E. Immunopathology of onchocerciasis: a role for eosinophils in onchocercal dermatitis and keratitis. In: Freeman DO, ed. Chemical Immunology. Basel: Karger. 1997:26-40.
44. Gutierrez-Pena E, Knab J, Buttner D. Neutrophil granule proteins: evidence for the participation in the host reaction to skin microfilariae of Onchocerca volvulus after diethylcarbamazine administration. Parasitology. 1996;113:403-414.